PortfoliosLab logo

Black Diamond Therapeutics, Inc. (BDTX)

Equity · Currency in USD · Last updated Oct 1, 2022

Company Info

ISINUS09203E1055
CUSIP09203E105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$2.23
Year Range$1.50 - $9.76
EMA (50)$3.02
EMA (200)$4.12
Average Volume$133.60K
Market Capitalization$86.12M

BDTXShare Price Chart


Chart placeholderClick Calculate to get results

BDTXPerformance

The chart shows the growth of $10,000 invested in Black Diamond Therapeutics, Inc. in Jan 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $428 for a total return of roughly -95.72%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%MayJuneJulyAugustSeptember
-39.20%
-21.75%
BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)

BDTXReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-47.35%-10.05%
6M-38.99%-20.85%
YTD-68.29%-24.77%
1Y-81.35%-17.75%
5Y-69.27%3.35%
10Y-69.27%3.35%

BDTXMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-21.76%-24.70%-11.78%-12.27%-30.45%45.56%42.28%-8.86%-47.02%
2021-22.71%13.04%-13.36%9.81%-50.75%-7.09%-21.58%5.65%-16.24%-9.46%-21.67%-11.17%
2020-5.02%-28.03%-7.56%48.46%5.43%7.96%-34.01%3.41%5.07%4.23%5.81%-3.87%

BDTXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Black Diamond Therapeutics, Inc. Sharpe ratio is -1.18. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MayJuneJulyAugustSeptember
-1.18
-0.77
BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)

BDTXDividend History


Black Diamond Therapeutics, Inc. doesn't pay dividends

BDTXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-96.23%
-25.25%
BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)

BDTXWorst Drawdowns

The table below shows the maximum drawdowns of the Black Diamond Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Black Diamond Therapeutics, Inc. is 96.65%, recorded on May 25, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.65%Jun 23, 2020486May 25, 2022
-53.95%Jan 31, 202033Mar 18, 202026Apr 24, 202059
-19.84%May 13, 202022Jun 12, 20206Jun 22, 202028
-17.8%Apr 28, 20204May 1, 20205May 8, 20209

BDTXVolatility Chart

Current Black Diamond Therapeutics, Inc. volatility is 57.64%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%MayJuneJulyAugustSeptember
57.64%
19.40%
BDTX (Black Diamond Therapeutics, Inc.)
Benchmark (^GSPC)